Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease
- 31 July 2009
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1792 (7), 625-633
- https://doi.org/10.1016/j.bbadis.2008.09.015
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Expression of the LRRK2 gene in the midbrain dopaminergic neurons of the substantia nigraNeuroscience Letters, 2008
- Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in DrosophilaThe EMBO Journal, 2008
- The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular AutophosphorylationPublished by Elsevier BV ,2008
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyThe Lancet Neurology, 2008
- A Drosophila model for LRRK2 -linked parkinsonismProceedings of the National Academy of Sciences of the United States of America, 2008
- Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPaseProceedings of the National Academy of Sciences of the United States of America, 2008
- The Roc domain of leucine‐rich repeat kinase 2 is sufficient for interaction with microtubulesJournal of Neuroscience Research, 2008
- Identification of potential protein interactors of Lrrk2Parkinsonism & Related Disorders, 2007
- LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activityBiochemical Journal, 2007
- The R1441C mutation of LRRK2 disrupts GTP hydrolysisBiochemical and Biophysical Research Communications, 2007